<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Haematology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FC10C2F9-6E9D-47E2-9489-AA868B49F0B4"><gtr:id>FC10C2F9-6E9D-47E2-9489-AA868B49F0B4</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lomas</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500306"><gtr:id>310D21BB-F466-432F-9429-004C00C33684</gtr:id><gtr:title>Pathobiology of the serpinopathies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500306</gtr:grantReference><gtr:abstractText>We have previously described a new class of disease that we have called the serpinopathies. These occur as a result of mutations in members of a family of proteins called the serine protease inhibitors or serpins. Mutations in these proteins cause them to change size and shape with either aberrant tissue deposition or loss of function. The serpinopathies encompass a wide spectrum of disease that is as diverse as cirrhosis, thrombosis, angioedema, emphysema and more recently dementia. We now propose to define the mechanisms by which mutations in members of the serpin superfamily cause the serpinopathies. In particular, we will use protein, cell and fly models to define how the abnormal proteins form, how they are handled by cells and how they cause cell death. In addition we will develop antibodies to neuroserpin so that we can detect the abnormal protein in animal and human tissues. Finally, we will define how the body clears these abnormal conformations of protein from the circulation and how they can excite white cells to cause inflammation and further tissue damage. Taken together, this programme of work will provide new insights into many different conditions. It is the long-term aim of our laboratory to develop strategies to treat the wide range of diseases that comprise the serpinopathies.</gtr:abstractText><gtr:technicalSummary>We have used biochemistry, biophysical analysis, crystallographic studies, cell biology, monoclonal antibodies, fly and mouse models to show that naturally occurring mutations in members of the serine proteinase inhibitor (serpin) superfamily result in abberant conformational transitions to cause disease. The most common of these is the sequential linkage between the reactive centre loop of one molecule and beta-sheet A of another. This process of loop-sheet polymerisation results in the retention of ordered serpin polymers within the cell of synthesis. Polymerisation of mutants of antitrypsin, antithrombin, C1 inhibitor and antichymotrypsin cause cirrhosis, thrombosis, angioedema and emphysema respectively. More recently we have described the same process in a neurone specific serpin, neuroserpin, to cause a novel dementia that we have called Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB). We have now described 4 mutants of neuroserpin that cause FENIB and have demonstrated a genotype-phenotype correlation that can be explained by the rate of intracellular polymerisation. In view of their common mechanism we have grouped these diseases of the serpins together as the serpinopathies and have used them as a paradigm for a broader class of disorders that we have called the conformational diseases. The serpinopathies provide a structurally defined model of protein aggregation that causes disease. We propose to use biochemistry, cell biology and fly models to address the following questions in this programme of work: a) What are the pathways that underlie conformational transitions of neuroserpin and can we develop strategies to block polymerisation in vitro and in vivo? b) How are polymers handled by neurones? c) How do polymers cause cell death in a Drosophila model of a serpinopathy? d) Can we develop monoclonal antibodies to detect polymeric neuroserpin in vitro and in vivo? and e) How are polymers cleared from the circulation and how do they mediate their pro-inflammatory effects within the lung? These studies, although focused on neuroserpin and a1-antitrypsin, are applicable to many of the mutations in serpins that underlie the serpinopathies. The long-term aim of our work is to understand mechanisms of disease caused by the serpinopathies (from pathological conformational transitions to pathways of cell toxicity) so that we can develop novel therapeutic strategies to treat the associated clinical syndromes.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1246538</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Small molecules to treat antitrypsin deficiency</gtr:description><gtr:id>4EAB61B1-9E6A-4C6F-88EF-972EED614B67</gtr:id><gtr:impact>Novartis will undertake a 'black box' screen to look for small molecules to block the polymerisation of mutant antitrypsin</gtr:impact><gtr:outcomeId>DF2F4FE1E7F-1</gtr:outcomeId><gtr:partnerContribution>Novartis will undertake a 'black box' screen to look for small molecules to block the polymerisation of mutant antitrypsin</gtr:partnerContribution><gtr:piContribution>Novartis will undertake a 'black box' screen to look for small molecules to block the polymerisation of mutant antitrypsin</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Small molecules to treat antitrypsin deficiency</gtr:description><gtr:id>B117D662-D510-495B-A5BF-9E96FB2FE923</gtr:id><gtr:impact>GSK will undertake a 'black box' screen to look for small molecules to block the polymerisation of mutant antitrypsin. We will help to characterise the hits</gtr:impact><gtr:outcomeId>62C580CD34E-1</gtr:outcomeId><gtr:partnerContribution>GSK will undertake a high throughput screen to look for small molecules to block the polymerisation of mutant antitrypsin. We will help to characterise the hits</gtr:partnerContribution><gtr:piContribution>GSK will undertake a 'black box' screen to look for small molecules to block the polymerisation of mutant antitrypsin. We will help to characterise the hits</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Development of the NSF for COPD</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>5ABD9C35-9DA2-4490-9ABC-C7B521ED58D3</gtr:id><gtr:impact>This grant funded work on antitrypsin deficiency. Insights in this disease were used to inform the Scientific Section of the NSF on COPD.

See 5.7</gtr:impact><gtr:outcomeId>0D5D46A98AA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>405163</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Grant to develop monoclonal antibodies to detect fragments of surfactant protein D</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>AC6821B4-DAE1-4D4C-BA4C-57102F2860E0</gtr:id><gtr:outcomeId>498EFB3E9160</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27170</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alpha-1 Foundation Grant/Alpha-1 Foundation</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Alpha-1 Foundation</gtr:fundingOrg><gtr:id>4D433A71-DB9B-4DF4-A325-D6CB60EFC01A</gtr:id><gtr:outcomeId>oWMG9RFE4dN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/EPSRC Life Science Interface Research Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DC92567D-2784-42D5-A0A7-E7C0398ABA01</gtr:id><gtr:outcomeId>243D8D4C8730</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3155690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT/MRC Neurodegenerative Diseases Strategic Award</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>25B57D88-83F8-48C8-916A-27E8958A825C</gtr:id><gtr:outcomeId>08167A9DB240</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220087</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Grant to identify small molelcules to treat alpha-1-antitrypsin deficiency</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>C54F0274-C5E0-4A8F-9ABE-5690F2A919FB</gtr:id><gtr:outcomeId>C7F6856986F0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>193232</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1A022C74-C247-444F-8A9A-EC9CC979C727</gtr:id><gtr:outcomeId>mr7wiWFG5Li0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187415</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C69508B7-46BA-4843-B7E1-31FBB9320274</gtr:id><gtr:outcomeId>1ADF69885900</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT/MRC Neurodegenerative Diseases Strategic Award</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>02DD5283-50FC-4329-96EC-DF56A823941F</gtr:id><gtr:outcomeId>08167A9DB241</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2467180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BB/H003843/1 Quantitative approaches to defining normal and aberrant protein homeostasis - co-applicant</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H003843/1</gtr:fundingRef><gtr:id>3D392AA9-9F0F-4C23-873E-D360060E4A61</gtr:id><gtr:outcomeId>C7AAE533E7D0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK PhD Research Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>58BEF515-A00E-4155-BEC0-DB366EBA67D9</gtr:id><gtr:outcomeId>5596A4BB0410</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD Training Programme for Clinicians</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4F60CA2B-7D6D-4C9F-97CC-9AA353212E67</gtr:id><gtr:outcomeId>oi94ZWBs3Lj0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>152986</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK grant</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>4FB4B134-8E8F-4723-B03D-2D82ED6F6024</gtr:id><gtr:outcomeId>33CAAB8A71D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1024240</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinician Scientist Fellowship</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>90A91152-BA4C-4240-9B96-BCCE44DA1358</gtr:id><gtr:outcomeId>FD0D88CF1D70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141477</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>12377E4C-AFA1-4FFE-A3F1-8F805E3A8F4F</gtr:id><gtr:outcomeId>GXb8tBEEBUv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>118690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF June Hancock Mesothelioma Research Fund grant</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>A105ADDF-06F4-4471-A40D-B965EFB6F3D4</gtr:id><gtr:outcomeId>2C7936DD49D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75294</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>7DA25B73-69F8-446C-993C-F148CBE3EF1F</gtr:id><gtr:outcomeId>240F415734F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40700</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Laurells Training Award</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Boehringer Ingelheim</gtr:fundingOrg><gtr:id>F404D04C-2F04-4EB9-AEC5-36FAC0A44E8A</gtr:id><gtr:outcomeId>BLW4LC8mmTP0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Cambridge Biomedical Research Centre</gtr:department><gtr:description>NIHR BRC Training and Capacity Building at the University of Cambridge</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>6FD84278-C7EA-4BEF-B15F-292CC2B01D7D</gtr:id><gtr:outcomeId>Bx7nP1Rr12H0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1797011</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A2D22E5D-BA5D-48AE-A68A-5B02E0665F45</gtr:id><gtr:outcomeId>ccGexUXBDPc0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NSF Guidelines on COPD</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:guidelineTitle>NSF for COPD</gtr:guidelineTitle><gtr:id>213A1F52-3EF1-467E-87FB-EAEF8B0F4346</gtr:id><gtr:impact>My work has contributed to the supporting scientific evidence to develop guidelines for the identification and management of individuals with COPD. ; The guidelines are currently being considered and have yet to be published.</gtr:impact><gtr:outcomeId>B081CB7EA6C</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Small molecules are being developed to stabilise abnormal conformations in alpha-1 antitrypsin in an attempt to develop small molecules to treat this disease.</gtr:description><gtr:id>1C2E9DD2-EDF2-4380-89B6-B1B894E55481</gtr:id><gtr:impact>This is an ongoing development.</gtr:impact><gtr:outcomeId>E04B5FC0F1B</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Small molecules to treat alpha-1 antitrypsin deficiency</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Monoclonal antibodies to the pathological conformer of antitrypsin</gtr:description><gtr:id>72BF7BAC-982F-4477-B557-96E0801B2786</gtr:id><gtr:impact>This reagent has allowed us to detect pathological polymers in vitro and in vivo and is being used to screen small molecules to block the polymerisation of Z antitrypsin. These will ultimately be used to treat the associated liver and lung disease</gtr:impact><gtr:outcomeId>7CFAF96D926</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibodies to the pathological conformer of antitrypsin</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D9FF21E7-F479-42DD-8158-BD59FEADB6B6</gtr:id><gtr:title>Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a65b97c25e25c188f705a93c531fd1"><gtr:id>02a65b97c25e25c188f705a93c531fd1</gtr:id><gtr:otherNames>Luheshi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>HDVfNBy8ANb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2683DA91-D3C9-45DF-9C12-179F2D836EF1</gtr:id><gtr:title>Characterisation of COPD heterogeneity in the ECLIPSE cohort.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c1b7d2be753ec279fd0e7f928bb26a4"><gtr:id>7c1b7d2be753ec279fd0e7f928bb26a4</gtr:id><gtr:otherNames>Agusti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>kadx1medkXN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C1EE641-9F33-4F75-B6AB-7E9FEEECCABB</gtr:id><gtr:title>The genetics of obstructive lung disease: big is beautiful.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/022db3eaa432db2d50da8b60d7b7a194"><gtr:id>022db3eaa432db2d50da8b60d7b7a194</gtr:id><gtr:otherNames>Hall IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>eKztA3ZTBbk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41D34834-1F61-4682-9038-E19DF141BA8F</gtr:id><gtr:title>Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ef00f4864728a04c5dea32521cafc83"><gtr:id>7ef00f4864728a04c5dea32521cafc83</gtr:id><gtr:otherNames>Patel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>XDQS6fJtc3J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>970476FA-73C2-42F5-B36E-94A2CA26C2DD</gtr:id><gtr:title>The molecular aetiology of the serpinopathies.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/561dad709a0c7a519b602a4ab102ee03"><gtr:id>561dad709a0c7a519b602a4ab102ee03</gtr:id><gtr:otherNames>Davies MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>DDD3532A6D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD30017F-872E-4145-ABDD-BB1BDFA28CEE</gtr:id><gtr:title>Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/add526325ded86beedad6c46b01ca21d"><gtr:id>add526325ded86beedad6c46b01ca21d</gtr:id><gtr:otherNames>Hersh CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>AworvXXENwa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED861598-5112-499D-A4E8-BC7F9B679B4B</gtr:id><gtr:title>Alpha1-antitrypsin deficiency and autophagy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>nh5WG8Ho44i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2937D740-C8DD-4B21-B3F6-2CA708E58D4E</gtr:id><gtr:title>Polymers and inflammation: disease mechanisms of the serpinopathies.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>F7A5F8588D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47CA28D7-9F10-4E96-8014-44AC47110B2B</gtr:id><gtr:title>Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>AB99A0A7A63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1961659C-2F5E-49CE-832A-2E7477D0EE64</gtr:id><gtr:title>Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebeabac3f65c1e9c91a9fce9147bb6b3"><gtr:id>ebeabac3f65c1e9c91a9fce9147bb6b3</gtr:id><gtr:otherNames>Vestbo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>ScxFpwEzh6U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A17378B-3158-4382-88D0-B8FCC962FDF1</gtr:id><gtr:title>Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93d6967938f175f313e3d4b9a894f8a"><gtr:id>d93d6967938f175f313e3d4b9a894f8a</gtr:id><gtr:otherNames>S?rheim IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>WuoSuLGJZju</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A41FC37-5F37-4C6A-BFDD-C29933B4C383</gtr:id><gtr:title>a1-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93d6967938f175f313e3d4b9a894f8a"><gtr:id>d93d6967938f175f313e3d4b9a894f8a</gtr:id><gtr:otherNames>S?rheim IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>YRNNLEY6Vym</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4A7BFE3-53C3-4AED-9D0B-FF9CF54214AD</gtr:id><gtr:title>Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8196b7176ccf1c65220a9f39a4c79fb8"><gtr:id>8196b7176ccf1c65220a9f39a4c79fb8</gtr:id><gtr:otherNames>Rival T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>B175DD7E370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A2826E9-A571-4A87-BD2C-A219136EE65B</gtr:id><gtr:title>Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c3f8b913c0f1c26cb10f35a40d4a9be"><gtr:id>0c3f8b913c0f1c26cb10f35a40d4a9be</gtr:id><gtr:otherNames>Brorsson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>fCHtLPs9fNL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>013BE50D-B7F5-4959-80A4-F3F88C6AF87F</gtr:id><gtr:title>Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/add526325ded86beedad6c46b01ca21d"><gtr:id>add526325ded86beedad6c46b01ca21d</gtr:id><gtr:otherNames>Hersh CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>WgCxDmwFrPv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37F0453C-6113-4467-A163-EAAD414845E0</gtr:id><gtr:title>The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78984a53d40253a6add2a563ac64a41d"><gtr:id>78984a53d40253a6add2a563ac64a41d</gtr:id><gtr:otherNames>Takehara S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>88725BF08AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7374AC1-CD0E-4639-AFB5-E00EE060D111</gtr:id><gtr:title>Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/441ee3f3305e1f1a8f11ae66e7191ec4"><gtr:id>441ee3f3305e1f1a8f11ae66e7191ec4</gtr:id><gtr:otherNames>Wan ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>cYfFskszBdT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>324F6636-967F-474E-A157-D141C717B06F</gtr:id><gtr:title>Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>faFBhhzLVEx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A7C90D6-4725-4EC8-9D6D-DB8D365288A5</gtr:id><gtr:title>Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f0059e1e679a1b9b0683c580d092e95"><gtr:id>2f0059e1e679a1b9b0683c580d092e95</gtr:id><gtr:otherNames>Munuswamy-Ramanujam G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>mPn4X1Rt7g1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A232495B-575A-43B1-8627-80C3203C58EB</gtr:id><gtr:title>Susceptibility to exacerbation in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30db543f92bcffc0b658fc5987b469f7"><gtr:id>30db543f92bcffc0b658fc5987b469f7</gtr:id><gtr:otherNames>Hurst JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>jxeDvX9dUfS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72981BDE-0424-4FF7-9AF5-C84B5133217F</gtr:id><gtr:title>Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a65b97c25e25c188f705a93c531fd1"><gtr:id>02a65b97c25e25c188f705a93c531fd1</gtr:id><gtr:otherNames>Luheshi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>8C535D0D907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3809015-13D9-4199-9FBD-968613C6CFA9</gtr:id><gtr:title>Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8cdb6b7072b2c83b15a109f92d40606"><gtr:id>b8cdb6b7072b2c83b15a109f92d40606</gtr:id><gtr:otherNames>Zhu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>ksB8NveujaH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C4C2CA3-1D76-4E75-BB4D-6E7395B2D4EA</gtr:id><gtr:title>Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44021ab601c79fa44b45d3dacdd9c0bc"><gtr:id>44021ab601c79fa44b45d3dacdd9c0bc</gtr:id><gtr:otherNames>DeMeo DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>sC2PZJinCDQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>047D33B8-8E1E-4CEE-B185-9D4D2DD3E07A</gtr:id><gtr:title>Using a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>SEB experimental biology series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fae788d36b173a228a158d9f2f13e221"><gtr:id>fae788d36b173a228a158d9f2f13e221</gtr:id><gtr:otherNames>Crowther DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1946-4959</gtr:issn><gtr:outcomeId>470409DF916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E82D55BC-B5BF-40E8-A730-CDC1911B533E</gtr:id><gtr:title>Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/561dad709a0c7a519b602a4ab102ee03"><gtr:id>561dad709a0c7a519b602a4ab102ee03</gtr:id><gtr:otherNames>Davies MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>ED19C25106B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B072A07-46CD-4425-8134-979286A91833</gtr:id><gtr:title>Protein misfolding and the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12261156b163aa7165a4fc782edd347"><gtr:id>a12261156b163aa7165a4fc782edd347</gtr:id><gtr:otherNames>Belorgey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>585d4ed0d66a47.92520379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F3C1006-3830-4189-8931-11EA56187E47</gtr:id><gtr:title>Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da3d30139af2f7d5f115630714930c3a"><gtr:id>da3d30139af2f7d5f115630714930c3a</gtr:id><gtr:otherNames>Kinghorn KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>535EC74CDA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEEA2C36-C997-4BF8-8534-67D7CE6CD0AD</gtr:id><gtr:title>Alzheimer's disease: insights from Drosophila melanogaster models.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba8cd4e2666db5508690fa7f0df47407"><gtr:id>ba8cd4e2666db5508690fa7f0df47407</gtr:id><gtr:otherNames>Moloney A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>daWueHFXwCs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>792D5EC8-AFC0-48A4-890B-864D4A44C7D2</gtr:id><gtr:title>Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aefb42c6bd5c5b9165dac1885914e07"><gtr:id>6aefb42c6bd5c5b9165dac1885914e07</gtr:id><gtr:otherNames>Mallya M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>0451C539A0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>515F2512-95C0-46E2-9675-5DEEDA034F7F</gtr:id><gtr:title>Variants in FAM13A are associated with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7fb85fc86d1efa8dad1a59bd70472ca"><gtr:id>c7fb85fc86d1efa8dad1a59bd70472ca</gtr:id><gtr:otherNames>Cho MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>B7D3YopoLaE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F93D27DF-E704-42C6-A36D-790009BFFF1F</gtr:id><gtr:title>A Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fae788d36b173a228a158d9f2f13e221"><gtr:id>fae788d36b173a228a158d9f2f13e221</gtr:id><gtr:otherNames>Crowther DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>77453EE0407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72C92AC2-B749-4659-8140-1CBF6199D89C</gtr:id><gtr:title>Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9538b66578a9f90dfa4375eda43a52"><gtr:id>5b9538b66578a9f90dfa4375eda43a52</gtr:id><gtr:otherNames>Nielsen HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>3E9B3B6BCA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A99486BD-2939-485A-9968-991ACC0E6B58</gtr:id><gtr:title>Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bbf132ef66269a67ed5c2a48c095326"><gtr:id>0bbf132ef66269a67ed5c2a48c095326</gtr:id><gtr:otherNames>Kong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>i6ReJUWtx49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D5A5581-041F-4E58-AABF-62B65B584144</gtr:id><gtr:title>A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6499f68ace8d7e6a2eeae99a83daf6"><gtr:id>ef6499f68ace8d7e6a2eeae99a83daf6</gtr:id><gtr:otherNames>Miranda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>MATEwsjWakN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>650B915E-794C-444F-BFC1-3100ACDA54D2</gtr:id><gtr:title>Genetic predisposition to chronic obstructive pulmonary disease: advances in alpha1-antitrypsin deficiency and the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>4E80B3BD1B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F63B61-E9D7-4F33-8A03-AD1E68C53902</gtr:id><gtr:title>The clinical impact of high resolution computed tomography in patients with respiratory disease.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e28dcb3c13f47e7b4921bfcafae99fef"><gtr:id>e28dcb3c13f47e7b4921bfcafae99fef</gtr:id><gtr:otherNames>Screaton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>qgJUrvKnALQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B96A27-455D-4EA5-86A2-A7598826371B</gtr:id><gtr:title>Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0396b96262cfc00bc545ab35b73fc343"><gtr:id>0396b96262cfc00bc545ab35b73fc343</gtr:id><gtr:otherNames>Rashid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>CrvKPBFNEaW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED47DAC4-6A29-4F8A-A87B-DBF7BF620F10</gtr:id><gtr:title>Conformational pathology of the serpins: themes, variations, and therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>AC7073A4793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CC6DE15-EF64-4704-ADBB-974D243A5223</gtr:id><gtr:title>alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>F87DD76CA53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B6D85B-27D9-44E7-87C0-70E697D3B325</gtr:id><gtr:title>Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/118b62d267ec9cc4c773db6fe0fdf413"><gtr:id>118b62d267ec9cc4c773db6fe0fdf413</gtr:id><gtr:otherNames>Sharp LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>A26A9FA27BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C65CCF8-E631-465D-8FD9-5095946B9716</gtr:id><gtr:title>The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6499f68ace8d7e6a2eeae99a83daf6"><gtr:id>ef6499f68ace8d7e6a2eeae99a83daf6</gtr:id><gtr:otherNames>Miranda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>51C1C3208BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5730DB3A-E7B5-403E-BF4D-4E7A18AAD77E</gtr:id><gtr:title>Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a694f01def3daaaf252c463627596062"><gtr:id>a694f01def3daaaf252c463627596062</gtr:id><gtr:otherNames>Kennedy SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>585d4ed6887b56.18714125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>927D349A-2F0D-452E-A1C8-EE57F0EEC533</gtr:id><gtr:title>Diagnosing COPD in non-smokers: splitting not lumping.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8eddec5bfb19c6be0cb61e1ae4132116"><gtr:id>8eddec5bfb19c6be0cb61e1ae4132116</gtr:id><gtr:otherNames>Chilvers ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pFKDpi9a1Ls</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07F97C6A-C7C5-47FD-A6FD-2EC8E0590C42</gtr:id><gtr:title>Neuroserpin: a serpin to think about.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6499f68ace8d7e6a2eeae99a83daf6"><gtr:id>ef6499f68ace8d7e6a2eeae99a83daf6</gtr:id><gtr:otherNames>Miranda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>E53963BBA4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A0F483D-1E28-4E12-A88C-481BA82F0EF9</gtr:id><gtr:title>Candidate genes for COPD in two large data sets.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da60bdfd574381fc6f7d595824b082c"><gtr:id>7da60bdfd574381fc6f7d595824b082c</gtr:id><gtr:otherNames>Bakke PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pK41vNa2e48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8C8830C-D743-4D9B-8DE8-0923A879AD90</gtr:id><gtr:title>Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85c262d94342bca702dffd6483191b72"><gtr:id>85c262d94342bca702dffd6483191b72</gtr:id><gtr:otherNames>Chiou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>30EA9160564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B77F3923-236E-442E-B615-865AEDA495F1</gtr:id><gtr:title>A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f3780fbac29c68d775616147365ea7b"><gtr:id>8f3780fbac29c68d775616147365ea7b</gtr:id><gtr:otherNames>Pillai SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>Kk2gJhoYcvU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85B0541F-8CC2-4169-BEE4-1BB21C02B497</gtr:id><gtr:title>Immune challenge induces N-terminal cleavage of the Drosophila serpin Necrotic.</gtr:title><gtr:parentPublicationTitle>Insect biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75a0ccdd3d356ec86344d1534ccfd378"><gtr:id>75a0ccdd3d356ec86344d1534ccfd378</gtr:id><gtr:otherNames>Pelte N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0965-1748</gtr:issn><gtr:outcomeId>nf95xtkTThn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96C58709-7B9A-4B75-BF1A-53CD615976C3</gtr:id><gtr:title>The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8cdb6b7072b2c83b15a109f92d40606"><gtr:id>b8cdb6b7072b2c83b15a109f92d40606</gtr:id><gtr:otherNames>Zhu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>83731739A4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1EBF087-4858-428A-B332-FDF31C71578B</gtr:id><gtr:title>Intracellular serpins, firewalls and tissue necrosis.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>4A4838D4E29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7448EB50-7E77-4FC2-A798-844969F51B9C</gtr:id><gtr:title>Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c027531dbd4f201d7cb44046a044ee"><gtr:id>f0c027531dbd4f201d7cb44046a044ee</gtr:id><gtr:otherNames>Malzer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>XfAqy2TyKqE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A70EE7F-B962-4EB9-9D8C-5C61FF3F701E</gtr:id><gtr:title>Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f3780fbac29c68d775616147365ea7b"><gtr:id>8f3780fbac29c68d775616147365ea7b</gtr:id><gtr:otherNames>Pillai SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>f7a3HQDFW7V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27715DEC-63DA-47FC-9A52-31D32731D20B</gtr:id><gtr:title>The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0f22304a03c5a9bc6a2b4948ab99ff"><gtr:id>fb0f22304a03c5a9bc6a2b4948ab99ff</gtr:id><gtr:otherNames>Lucas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>ZMSrRYtU7sb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AF0601-F447-46B3-A657-188729E466EC</gtr:id><gtr:title>25th anniversary Transatlantic Airway Conference: Protein misfolding and obstructive lung disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>Gvb22t2rhGW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F017653-14B9-4F32-A45B-C7E5826D52B0</gtr:id><gtr:title>Alpha-helix targeting reduces amyloid-beta peptide toxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5e243007b016cd917a432ada05fd7b"><gtr:id>5b5e243007b016cd917a432ada05fd7b</gtr:id><gtr:otherNames>Nerelius C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>2C4C684FFF2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3741234-8371-4890-A567-1ACFF4A27A8A</gtr:id><gtr:title>Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>592F8E357C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EAF877F-1333-427D-8AE3-68CCF33E4A49</gtr:id><gtr:title>What can naturally occurring mutations tell us about the pathogenesis of COPD?</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>8A34F9002C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D5CC667-BB72-4BB0-8D33-14D3C6878A7D</gtr:id><gtr:title>CTLA4 gene polymorphisms are associated with chronic bronchitis.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8cdb6b7072b2c83b15a109f92d40606"><gtr:id>b8cdb6b7072b2c83b15a109f92d40606</gtr:id><gtr:otherNames>Zhu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>cpNcJFdJ3LH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8492F5E9-A83B-4730-88A9-C603DEBBBEFC</gtr:id><gtr:title>Inhaled all-trans retinoic acid in an individual with severe emphysema.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/484c33072e855ab9d1b13ab9a6d4a052"><gtr:id>484c33072e855ab9d1b13ab9a6d4a052</gtr:id><gtr:otherNames>Frankenberger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>rZPmwgvzm8o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51DAFEFF-B72B-44C5-944A-54C663B55A7E</gtr:id><gtr:title>Dietary antioxidants and asthma in adults.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ef00f4864728a04c5dea32521cafc83"><gtr:id>7ef00f4864728a04c5dea32521cafc83</gtr:id><gtr:otherNames>Patel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>T2DvWBRQwa1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A13C2A-9FDB-4D7F-B63E-0EF44B4A1E46</gtr:id><gtr:title>Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>c9zQv6neCLz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA286427-DF01-48B4-8116-576F5C0F5E71</gtr:id><gtr:title>Defining the mechanism of polymerization in the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Yz3Di63FTPG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B75B297-2096-444F-8F82-AB4700EE8312</gtr:id><gtr:title>Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a275f6dc84f36fec5937aed4ea02da1"><gtr:id>0a275f6dc84f36fec5937aed4ea02da1</gtr:id><gtr:otherNames>Kroeger H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>49F1E0517B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E19F3944-32A6-44F2-8BAB-53D031199885</gtr:id><gtr:title>Inhibitory activity of the Drosophila melanogaster serpin Necrotic is dependent on lysine residues in the D-helix.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f91138ba91fe762af82edfc90bc6dd"><gtr:id>67f91138ba91fe762af82edfc90bc6dd</gtr:id><gtr:otherNames>Robertson AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>6ECBB49390C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB90E2D7-1A40-43B5-862E-A472E157E772</gtr:id><gtr:title>Sex differences in emphysema and airway disease in smokers.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90fa2e20be9fa1da2ecfafc2603b48b0"><gtr:id>90fa2e20be9fa1da2ecfafc2603b48b0</gtr:id><gtr:otherNames>Camp PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>EN7q3xnySV7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1222ABF-4481-45A2-AC41-CCDE991101B4</gtr:id><gtr:title>Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f9ede41d14c2eca352cdf7b9ae2893a"><gtr:id>6f9ede41d14c2eca352cdf7b9ae2893a</gtr:id><gtr:otherNames>Foreman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>S89ow4fLSC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27852DB1-8590-4030-B44B-637EE1DD63B5</gtr:id><gtr:title>Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>7ACF9228360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58564CE5-7E9C-4345-9504-EBD8E093133C</gtr:id><gtr:title>pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12261156b163aa7165a4fc782edd347"><gtr:id>a12261156b163aa7165a4fc782edd347</gtr:id><gtr:otherNames>Belorgey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>D2E0A9766E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9291A8EF-B3E5-4F93-B245-48F977682875</gtr:id><gtr:title>Smoking related COPD and facial wrinkling: is there a common susceptibility?</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ef00f4864728a04c5dea32521cafc83"><gtr:id>7ef00f4864728a04c5dea32521cafc83</gtr:id><gtr:otherNames>Patel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>YBW8E456pK2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B7E9B2B-2453-4140-A99D-5DC9B7EC060C</gtr:id><gtr:title>The selective advantage of alpha1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>6B90002A429</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500306</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>